News Center
The two antibiotic products, Tigecycline for Injection and Moxifloxacin Hydrochloride Sodium Chloride Injection, began commercial production and were approved for sale this year. They are the first two of formulation products that our wholly-owned subsidiary Chongqing Saintsun has developed, commercially produced and initiated the marketing.
Copyright(C)2024,Beijing Lunarsun Pharmaceutical Co.,Ltd. All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle 31fabu Copyright Notice